Johnson & Johnson just announced the launch of a Phase 3 clinical trial for its COVID-19 vaccine candidate. But what does this step in the process really mean? We asked two experts whose job it is to test vaccines to help demystify the clinical trial process—step by step.
Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.
Thanks to their groundbreaking solutions for treating malnourished kids, saving mothers' lives and more, these big thinkers—all winners of Johnson & Johnson's GenH Challenge—are poised to reshape healthcare for future generations.
Who's more invested in kids' safety than parents? No one. That's what makes these women such powerhouses: They use their maternal instincts and insight to ensure the products they develop are good enough to use on their own kids.
Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he's hoping to combat this tropical scourge and another disease that kills over a million worldwide.